Local Recurrence Due to Rectal Cancer in Sweden

Overview

The aim of this retrospective national registry study is to validate the reporting of local recurrence in the registry. Another aim is to identify preoperative risk factors for local recurrence. This can in turn indicate the need for a more intense follow-up. The treatment of local recurrence, including the impact of the multidisciplinary team conference (MDT) and the surgical procedure and the referral pathways of local recurrences will also be determined. We aim to evaluate treatment outcome after local recurrence for patients operated or treated between 2007-2018.

Full Title of Study: “Local Recurrence Due to Rectal Cancer in Sweden – the Actual Incidence, Treatment and Outcome After Treatment”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 1, 2021

Interventions

  • Procedure: Treatment for local recurrence with surgery or other treatments
    • All types of treatment for local recurrence will be evaluated

Arms, Groups and Cohorts

  • Patients with local recurrence

Clinical Trial Outcome Measures

Primary Measures

  • Number of local recurrences
    • Time Frame: Between 2007-2018
  • 3 year survival
    • Time Frame: 3 years

Secondary Measures

  • Percentage R0 resection after local recurrence
    • Time Frame: 1-2 months after initiated treatment
  • MDT effect on treatment of local recurrence
    • Time Frame: 1-3 months after diagnosis of recurrence

Participating in This Clinical Trial

Inclusion Criteria

  • Rectal cancer with a curative intent Exclusion Criteria:

  • Rectal cancer without curative intent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Sahlgrenska University Hospital, Sweden
  • Provider of Information About this Clinical Study
    • Principal Investigator: Eva Angenete, PI – Sahlgrenska University Hospital, Sweden

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.